{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "IPAR",
  "name": "Interparfums, Inc.",
  "url": "https://orbyd.app/dossiers/IPAR/",
  "json_url": "https://orbyd.app/dossiers/IPAR.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Quality-defensive re-rating (~+39% YTD, ~$122) is maturing: Q2 net sales grew just 2% to $341M with anchor license Lacoste -19%, yet Canaccord chased its target to $141 (2026-07-23) as sell-side catches up to decelerating growth. Full Q2 EPS print 2026-08-04, on a guide that embeds a ~5% earnings decline, is the binary test — late-cycle flow, not an accelerating narrative.",
  "invalidation_trigger": "A weekly close below $110 loses the June–July breakout shelf and signals the quality-defensive flow bid unwinding toward the $95–97 MA cluster; confirmation would be the 2026-08-04 print trimming the $1.48B/$4.85 FY guide, or the rotation theme rolling to saturated.",
  "catalyst_date": "2026-08-04",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation",
    "m-and-a-special-situations"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Price has outrun sell-side: avg PT $106, high $123 (MarketBeat 2026-07-10) — spot above the high target. Watch for target catch-up vs a flow unwind.",
    "License pipeline durable: Lacoste FY $108M (+28%), 20yr Nautica + David Beckham deals, Guess extended to 2048.",
    "Stretched ~25% above 90-DMA ($97); no fresh fundamental catalyst defends the gap into the print.",
    "Full Q2/H1 financials (EPS + margins) after close 2026-08-04; call 2026-08-05. Treat as blackout for fresh sizing within 3 trading days (~from 2026-07-30).",
    "Q2 net sales (2026-07-22): $341M +2%; H1 $686M +2%. US +18%, Europe -4%. Lacoste -19% Q2 / -16% H1 — anchor license reversed from prior +28% FY; watch for spread to other core licenses.",
    "FY2026 is an investment/trough year: guide EPS $4.85 (~-5% YoY) on sales ~$1.48B (+1%); 2027 rollout (Off-White, Longchamp) is where reacceleration is priced.",
    "Canaccord PT $123 to $141, Buy (2026-07-23) now above spot; broader target set dispersed (WallStreetZen ~$111 mean, lows ~$85). Sell-side catch-up is late-cycle confirmation, not a leading signal.",
    "Do not conflate Interparfums Inc (NASDAQ:IPAR, USD) with parent Interparfums SA (Euronext:ITP, EUR) — separate reports; euro revenue/EBIT guidance headlines belong to the parent, not IPAR."
  ],
  "body_markdown": "## Current Thesis\nInterparfums has re-rated ~39% YTD and traded to $122.55 on 2026-07-24 (+2.3% day, ~23x trailing EPS, ~$3.9B cap), pressing the upper end of a $77–$129 52-week range. The advance is a rotation-into-quality-defensives bid rather than earnings growth: Q2 net sales (reported 2026-07-22) rose just 2% to $341M, first-half sales 2% to $686M, and FY2026 guidance still sits at EPS $4.85 — roughly a 5% decline versus 2025 as capital is redirected into emerging labels ahead of a 2027 rollout. The tape has now dragged sell-side up to it, with Canaccord lifting its target to $141 on 2026-07-23; that repricing is late-cycle confirmation, arriving after the move rather than before it. Full Q2 financials land after the close on 2026-08-04 (call 2026-08-05), and that print — on a guide already embedding falling earnings — is the binary test of whether fundamentals can backfill a ~25x forward multiple.\n\n## Bull Case\n- US demand inflected hard: US-based net sales +18% in Q2 and +10% in H1 (reported 2026-07-22), offsetting a 4% European decline on tough comps and Middle East softness.\n- Portfolio breadth carried the quarter: Jimmy Choo +23% Q2, Donna Karan/DKNY +28% Q2, Ferragamo +41% Q2 (2026-07-22 release) — a broad set of labels contributing while one lagged.\n- Ex-war organic growth was +4% in Q2; management flagged a 3% Q2 / 2% H1 drag from the Middle East conflict, a headwind that can fade rather than a structural demand problem.\n- Sell-side is finally chasing the tape: Canaccord Genuity raised its target from $123 to $141 and reiterated Buy (2026-07-23), now above spot, against an average that sat near $106 into early July.\n- License pipeline still building the 2027 case: 20-year Nautica and David Beckham deals and Guess extended to 2048 support the reacceleration management is investing toward.\n- Balance sheet funds the trough year cleanly — $237M cash/short-term investments and $692M working capital at Q1 (2026-04-21) — with a $0.80/qtr dividend (~2.6% yield) paying holders to wait.\n\n## Bear Case\n- The anchor license cracked: Lacoste fragrance sales fell 19% in Q2 and 16% in H1 (2026-07-22), reversing the +28% FY figure that underpinned the prior bull frame and leaving a visible hole in the compounding-license story.\n- Growth is decelerating into the re-rating: +2% consolidated net sales is a modest print, and FY2026 EPS is guided to $4.85, a ~5% year-on-year decline on sales +1%. A ~39% YTD move on falling earnings is pure multiple expansion.\n- Targets are dispersed and several sit below spot: WallStreetZen shows a ~$111 one-year mean and low-end estimates near $85 against a $122.55 tape — Canaccord's $141 is the outlier, not the consensus.\n- Coverage is turning late-cycle: the name appeared in \"defensive stocks that may fall off a cliff\" framing (2026-07-10), and Q2 headlines described \"modest\" growth (TipRanks/GuruFocus, 2026-07-22).\n- Extension persists: spot near $122 remains well above the ~$97 90-DMA of the last read, with no fresh fundamental catalyst before the 2026-08-04 print to defend the gap.\n- The binary skews unfavorably: a reaffirm-only Q2 report on -5% EPS guidance hands flow buyers little new to hold, while any guide trim or downbeat Lacoste commentary reprices the multiple lower.\n\n## Setup & Price Structure\n- Last $122.55 on 2026-07-24 (+2.3%); 52-week range ~$77.21–$128.62 (stockanalysis, late July), placing the stock within ~5% of its high.\n- The advance built off the $95–97 MA cluster through a $110–115 breakout shelf into July and has held that shelf through the Q2 net-sales print.\n- Momentum stays extended above all major moving averages after a ~26% one-month run into mid-July; the pullback that would reset the setup has not arrived.\n- Overhead: the 52-week high near $129 and GuruFocus GF Value $137.80. Support: the $110–112 shelf first, then the $95–97 MA cluster on a deeper unwind.\n- Valuation is not the objection — ~23x trailing EPS of $5.27, ~25x the $4.85 forward guide — so the re-rate is a factor/flow event more than a bubble multiple.\n\n## Catalyst Calendar (next 30 days)\n\n*No upcoming dated catalysts on file — the dated entries below have passed.*\n\n## Elapsed catalysts\n\n- 2026-08-04 (after close): full Q2/H1 financial results including EPS and margins — the binary event for the re-rating; the market watches whether the ~$1.48B/$4.85 FY guide holds and how management frames Lacoste. *(passed 5d ago)*\n- 2026-08-05: management conference call — commentary on US momentum, European softness, the Middle East drag, and any pull-forward of the 2027 license rollout. *(passed 4d ago)*\n- Q2 dividend declaration expected alongside the print (last $0.80/qtr paid 2026-06-30). *(passed 40d ago)*\n- Analyst-target repricing in-flight: watch for follow-on revisions after Canaccord's 2026-07-23 move to $141 to confirm or fade the sell-side catch-up. *(passed 17d ago)*\n\n## What Would Change Our Mind\n- Bullish re-acceleration: a weekly close holding above ~$129 alongside a 2026-08-04 print that raises or pulls forward the 2027 guide and stabilizes Lacoste would turn the maturing re-rate back into a leg worth sizing.\n- Thesis break: a weekly close below $110 loses the June–July breakout shelf and signals the quality-defensive flow bid unwinding toward the $95–97 MA cluster. A confirming fundamental tell would be the 2026-08-04 report trimming the $1.48B/$4.85 guide, Lacoste weakness bleeding into other core licenses, or the rotation theme rolling to saturated with no replacement bid.\n- Base case is to stand aside into the print: chasing 52-week highs on +2% net-sales growth ahead of a binary EPS event that already embeds a ~5% earnings decline is a poor entry; a post-print base or a pullback to the shelf offers a cleaner one.\n\n## Correlation Notes\n- Affordable-luxury / beauty complex: tracks loosely with Estée Lauder (EL), e.l.f. (ELF), Coty (COTY) and Ulta (ULTA) on the \"lipstick effect\" consumer read; a weak EL print would isolate IPAR's US-driven strength as idiosyncratic.\n- Consumer-discretionary rotation factor: the re-rate is a flight-to-quality-defensive flow, so it moves with defensive-factor rotation more than with fragrance end-demand; a risk-on rotation back into growth/AI names removes the bid.\n- FX: reports in USD while a majority of sales are European-based, so a firmer EUR/USD flatters reported growth (favorable FX aided the +2% H1); a sharp dollar rally trims the tailwind.\n- Geopolitics: an explicit 3% Q2 / 2% H1 sales drag from the Middle East conflict (2026-07-22) ties near-term regional sales to that situation de-escalating or worsening.\n- Related listing: parent Interparfums SA (Euronext: ITP) reports on a separate cadence in euros; its H1 margin/guidance headlines can spill sentiment onto IPAR even though the US entity's figures differ.",
  "first_seen": "2026-07-07",
  "last_analyzed": "2026-07-26T12:26:55+00:00",
  "last_synthesized": "2026-07-26",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}